Clinical Guides
Ulcerative Colitis
An India-contextualised, clinically focused guide to recognising ulcerative colitis, excluding infection, staging activity, sequencing therapy safely and coordinating long-term bowel, cancer, vaccine and pregnancy care.
MedNext Academy | 12 min read
Ulcerative Colitis
An India-contextualised, clinically focused guide to recognising ulcerative colitis, excluding infection, staging activity, sequencing therapy safely and coordinating long-term bowel, cancer, vaccine and pregnancy care.
Summary
Ulcerative colitis (UC) is a chronic inflammatory disease of the colon in which mucosal inflammation usually begins in the rectum and extends proximally in a continuous pattern. Extent, activity, extraintestinal manifestations, comorbidity, prior drug exposure and the patient’s priorities all matter. Bloody diarrhoea, urgency, nocturnal stool, tenesmus, abdominal pain, fatigue and weight loss are common, but infection, medication injury and Crohn disease can mimic it. A diagnosis should not be made from symptoms alone or from a single inflammatory marker.
The first assessment asks whether the patient is stable and whether acute severe ulcerative colitis (ASUC) is possible. Stool cultures and Clostridioides difficile testing are important before immunosuppression is escalated. Colonoscopy with biopsies, usually limited when severe colitis is suspected, establishes extent and excludes alternatives. For mild-to-moderate disease, 5-aminosalicylate therapy is commonly the foundation; corticosteroids induce remission when needed but are not maintenance treatment. Moderate-to-severe disease may require biologic or targeted small-molecule therapy, chosen with a specialist. Failure to respond in ASUC requires rescue therapy or surgery without unsafe delay. This India-focused MedNext draft is reviewed educational guide; it is educational and does not replace a local gastroenterology or surgical pathway.
Good care also includes a baseline record of stool pattern, haemoglobin, albumin, inflammatory markers, weight, disease extent and treatment exposure. That record makes later decisions safer because symptom improvement can coexist with active mucosal disease, while functional symptoms can persist after inflammation settles. Patients should be told who to contact during a flare, which symptoms require emergency attendance and why antibiotics, steroids or antidiarrhoeals should not be self-started. The aim is durable control with the least treatment harm, not merely a short-term reduction in visible blood.
How Common Is It?
UC occurs worldwide and incidence has risen in many newly industrialising regions, including parts of Asia, but Indian estimates vary by city, health-care access, diagnostic practice and whether hospital or community populations are counted. A local clinic should not convert a single study percentage into a national prevalence claim. The practical message is that chronic bloody diarrhoea is not rare enough to dismiss as piles, “food intolerance” or recurrent infection, particularly when symptoms persist, cause nocturnal waking or are accompanied by anaemia and raised inflammatory markers.
Disease burden is not captured by stool frequency alone. A patient with urgency who cannot travel to work, a student avoiding examinations, or someone with repeated steroid courses may have substantial impairment despite modest endoscopic inflammation. Conversely, severe colitis can develop quickly in a patient without a long history. Regional barriers include delayed specialist access, out-of-pocket endoscopy and biologic costs, tuberculosis screening logistics, medicine availability and stigma around bowel symptoms. Assessment should document clinical, biochemical and patient-reported burden, not simply label activity from one symptom. Indian gastroenterology services may need shared-care plans linking primary care, district hospitals, endoscopy units, pathology and colorectal surgery.
Risk Factors
UC is not caused by one food or by a patient’s emotional state. Family history of inflammatory bowel disease increases susceptibility, while genetic, immune, microbial and environmental factors interact. Cigarette smoking has a complex association and is not a treatment; advising a person to start smoking is unsafe. Recent antibiotics, hospital exposure, travel, contaminated food, immunosuppression and prior enteric infection alter the probability of infectious colitis and must be asked about before attributing diarrhoea to UC. Non-steroidal anti-inflammatory drugs may aggravate symptoms in some patients, but stopping essential medicines should be clinician-led.
Review previous appendicectomy, recurrent perianal disease, oral ulcers, eye inflammation, joint symptoms, psoriasis, liver disease and venous thromboembolism risk. These may signal a phenotype or extraintestinal complication rather than a simple bowel flare. Ask about tuberculosis exposure, hepatitis B, HIV risk and vaccination history before advanced immunosuppression. Pregnancy plans, contraception, fertility concerns, osteoporosis risk, diabetes, hypertension and previous malignancy change the treatment conversation. A medicine list should include steroids obtained without prescription, antibiotics, antidiarrhoeals, complementary products and biologics from another facility. Risk stratification is dynamic: extent, deep ulceration, high inflammatory burden, repeated steroid dependence and previous admission predict a more complicated course and justify early specialist planning.
Diagnosis
Diagnosis combines a compatible history, examination, exclusion of infection and inflammatory mimics, endoscopic assessment and histology. Do not let a normal haemoglobin or a negative initial stool result overrule a concerning course. Record baseline disease extent and severity so later response can be judged against more than symptoms.
History
Clarify onset, number and character of stools, visible blood, urgency, nocturnal symptoms, tenesmus, pain, fever, weight change, appetite and functional impact. Ask about recent antibiotics, hospitalisation, travel, sick contacts, untreated water, sexual exposure, tuberculosis contact, NSAIDs and new medicines. Establish previous endoscopy, pathology, steroid exposure, admissions and response to 5-ASA or biologic therapy. Screen for painful red eye, photophobia, oral ulcers, joint swelling, back stiffness, skin lesions, jaundice and thrombotic symptoms. Menstrual, pregnancy and fertility history should be included when relevant.
Examination
Assess hydration, pulse, blood pressure, temperature, orthostatic symptoms, pallor, weight and nutritional state. Abdominal tenderness, distension, guarding or reduced bowel sounds may signal a complication. Examine the perianal region when Crohn disease or sepsis is possible, and look for arthritis, erythema nodosum, pyoderma, uveitis or jaundice. In suspected ASUC, count stools and blood, assess systemic toxicity and document abdominal findings repeatedly.
Investigations
Send stool culture or molecular testing according to local availability and test for C. difficile; consider ova and parasites when exposure supports it. Obtain full blood count, CRP or ESR, albumin, electrolytes, renal and liver profile, iron studies and faecal calprotectin when it will clarify inflammation. Flexible sigmoidoscopy with biopsies is often safer than full colonoscopy in severe disease; complete ileocolonoscopy is used when stable and diagnostic uncertainty remains. Abdominal radiography or CT is reserved for suspected dilatation, perforation, obstruction or another complication. Before advanced therapy, screen for tuberculosis and hepatitis B and update risk-based vaccines.
Differential Diagnosis
Infectious colitis must be actively excluded, particularly C. difficile after antibiotics or hospital exposure, enteric bacterial disease, amoebiasis, tuberculosis and sexually transmitted proctitis when relevant. A negative test can be falsely reassuring if collected after antibiotics or if the assay does not cover the suspected pathogen; persistent illness needs reassessment. Ischaemic colitis, colorectal cancer, microscopic colitis, coeliac disease, bile-acid diarrhoea, drug-induced injury and radiation injury may resemble inflammatory bowel disease.
Crohn colitis is distinguished by patchy or transmural disease, ileal involvement, strictures, fistulae, granulomas or perianal disease, although no single feature is absolute and treatment can overlap. Behçet disease, intestinal spirochaetosis and immune-mediated conditions are context-dependent considerations. Solitary rectal ulcer, prolapse and haemorrhoids do not explain systemic inflammation or extensive colitis.
Histology is interpreted with clinical and endoscopic context. Chronicity markers support IBD but do not by themselves identify UC. A patient with a first severe presentation may need serial examination, imaging and repeat endoscopy rather than a premature permanent label. Reconsider the diagnosis when there is persistent fever, disproportionate pain, small-bowel disease, poor response to appropriate treatment, unusual pathology or repeated positive infection tests. Avoid empirical immunosuppression until dangerous infection has been reasonably addressed.
Management
Treatment is a shared decision based on activity, extent, prior response, comorbidity, pregnancy plans, route preference, cost and the need to avoid steroid exposure. Mild proctitis may be treated with rectal 5-ASA; left-sided or extensive mild-to-moderate disease generally uses topical plus oral 5-ASA when tolerated. If response is incomplete, clinicians may optimise adherence, dose and route before moving to a short induction course of corticosteroid. Budesonide formulations can be appropriate for selected disease locations, but steroid choice is specialist- and formulation-dependent.
Moderate-to-severe UC or steroid-dependent disease needs early gastroenterology review. Options include anti-TNF agents, vedolizumab, ustekinumab, IL-23-directed agents, JAK inhibitors and other locally approved therapies; comparative choice depends on urgency, infection and clot risk, prior biologic exposure, pregnancy and access. Treat-to-target care combines symptoms, biomarkers and planned endoscopic reassessment. Thiopurines are not rapid induction drugs and require safety assessment; combination decisions should be specialist-led.
ASUC is an inpatient emergency. Give supportive care, test stool pathogens, provide thromboprophylaxis unless contraindicated, involve gastroenterology and colorectal surgery early, and use monitored intravenous corticosteroids with objective review. Non-response should prompt rescue biologic or calcineurin-inhibitor strategy, or colectomy, within a time-bound pathway. Toxic megacolon, perforation, severe haemorrhage or worsening systemic toxicity require urgent surgery. Never allow repeated outpatient steroids to postpone definitive care.
Prescribing Information
5-ASA products differ in release mechanism, dose and renal safety monitoring; prescribing should match disease location and the authorised Indian formulation. Explain adherence, expected onset, rectal administration and warning symptoms. Check renal function at baseline and periodically according to product information and local protocol. Corticosteroids should be used for induction, with a documented taper and bone, glucose, blood-pressure and infection-risk plan; they should not become maintenance by default. A flare while tapering may represent undertreated disease, infection or steroid dependence and needs review.
Before a biologic, JAK inhibitor or other advanced therapy, document infection history, tuberculosis and hepatitis B assessment, vaccination review, cancer history, pregnancy intention and baseline blood tests. Avoid live vaccines during relevant immunosuppression; coordinate inactivated vaccines and seasonal influenza, COVID-19 and pneumococcal protection according to age and risk. JAK inhibitors require careful discussion of thrombosis, cardiovascular and malignancy warnings and should not be treated as interchangeable with biologics. Thiopurines need blood-count, liver and interaction monitoring and are not suitable for every patient.
Avoid routine NSAIDs and unadvised antimotility drugs during severe bloody flares. Iron, vitamin D, calcium and thromboprophylaxis are selected by deficiency, immobility and risk. This guide intentionally provides no universal dose or brand: local formulary, specialist prescribing, renal and hepatic function, pregnancy and infection results must govern the prescription. Urgent review is needed for fever, severe pain, distension, dehydration or rapidly rising stool frequency.
When to Refer
Refer promptly to gastroenterology for persistent rectal bleeding or diarrhoea, raised faecal calprotectin or CRP, anaemia, weight loss, nocturnal symptoms, suspected IBD, recurrent steroid use or treatment failure. The referral should include stool results, antibiotic and travel history, blood count, inflammatory markers, albumin, renal function, medication exposure and any extraintestinal findings. Direct access to endoscopy and pathology is valuable, but a stable patient should not be delayed while waiting for a perfect panel.
Same-day hospital assessment is needed for suspected ASUC: frequent bloody stools with tachycardia, fever, anaemia, high inflammatory markers, dehydration, hypoalbuminaemia, severe abdominal pain or systemic toxicity. Contact colorectal surgery early even when medical rescue is being attempted. Transfer to a centre with endoscopy, imaging, intensive care, gastroenterology and colorectal surgery if local capability is limited.
Refer to ophthalmology urgently for painful red eye or visual change, rheumatology or dermatology for disabling inflammatory manifestations, hepatology for cholestatic tests or suspected primary sclerosing cholangitis, and maternal-fetal medicine when pregnancy is complicated by active disease or advanced therapy questions. Cancer surveillance planning belongs with the treating team after disease duration and extent are confirmed. Document who will own follow-up; an unassigned referral is not a safety plan.
Red Flags
Severe abdominal pain, distension, guarding, persistent vomiting, inability to pass stool or flatus, fever, confusion, fainting, hypotension, marked tachycardia, oliguria or rapidly worsening bloody diarrhoea may indicate toxic megacolon, perforation, sepsis, haemorrhage or severe dehydration. These are emergency signs, not indications to increase oral steroids at home. A patient with suspected ASUC needs urgent hospital assessment, serial observations, blood tests and imaging or endoscopy chosen by the specialist team.
A painful red eye with photophobia or reduced vision may be sight-threatening uveitis. A hot swollen joint, severe skin ulcer, jaundice, calf swelling, pleuritic pain or sudden breathlessness may represent an extraintestinal emergency, thrombosis or hepatobiliary disease. New fever on advanced therapy can be infection even when bowel symptoms are prominent.
Cancer warning patterns include a new change in bowel habit, persistent bleeding despite control, iron-deficiency anaemia, unexplained weight loss, a mass or obstructive symptoms. Pregnancy with active bloody diarrhoea, dehydration or medication interruption deserves coordinated specialist advice. Families should receive a written escalation plan with local emergency numbers, because delay is especially dangerous when a person has previously improved with steroids and assumes every flare is routine.
Indian Clinical Context
Indian practice requires adaptation rather than simple importation of a high-income-country algorithm. ECCO and AGA guidance provide evidence-based sequencing, while Indian IBD clinicians must also account for endemic infections, tuberculosis exposure, hepatitis B prevalence, antimicrobial resistance, variable access to faecal calprotectin and pathology, and the price or availability of biologics. A positive tuberculosis screen does not automatically exclude every therapy, but it mandates a documented infectious-disease plan. Amoebiasis and other enteric infections can mimic UC and deserve locally sensible testing.
Discuss affordability, travel to infusion centres, cold-chain reliability, privacy, nutrition and the ability to attend monitoring visits. Generic or biosimilar choices may improve access, but interchangeability and pharmacovigilance should follow institutional policy. Vaccination review is particularly important before immunosuppression; do not assume that childhood records are complete. Explain that complementary diets or unregulated products cannot replace infection exclusion and disease-modifying treatment.
Pregnancy is safest when UC is controlled before conception. Most maintenance therapies are considered on an individual risk-benefit basis, whereas uncontrolled inflammation, malnutrition and steroid exposure can harm parent and fetus. Coordinate gastroenterology, obstetrics and paediatrics; do not stop effective therapy abruptly. This draft is an India-jurisdiction educational resource, reviewed educational guide, not a national protocol or a claim that every cited international recommendation is locally licensed.
NMC Competency Mapping
NMC CBME learning in medicine expects learners to approach chronic diarrhoea, gastrointestinal bleeding, anaemia, inflammatory bowel disease and acute abdomen with safe clinical reasoning. UC can map to competencies involving history and examination of the gastrointestinal system, formulation of differential diagnosis, interpretation of stool studies, inflammatory markers, endoscopy and biopsy, and selection of referral urgency. The observable skill is not naming a drug from memory; it is recognising when infection must be excluded and when the patient is too ill for outpatient care.
An undergraduate case can ask the learner to distinguish chronic bloody diarrhoea from dysentery, Crohn colitis and colorectal cancer, then present a concise referral. Another can require an ASUC handover including stool count, blood pressure, pulse, haemoglobin, CRP, albumin, abdominal findings, venous-thromboembolism risk and surgical involvement. A counselling station can test steroid safety, vaccine planning, adherence, fertility and shared decisions around advanced therapy.
NMC mapping does not authorise independent prescribing of biologics, JAK inhibitors, intravenous steroids or rescue therapy. Students should use local formularies and supervision, explain uncertainty and document safety-netting. Assessment should reward infection control, respectful bowel history, recognition of extraintestinal disease and timely escalation, alongside factual knowledge of continuous rectal-to-proximal inflammation.
Key Exam Pearls for NEET PG
UC classically produces continuous mucosal inflammation beginning in the rectum; Crohn disease is more often patchy, transmural, ileocolonic or perianal, but overlap means pattern is not a standalone diagnosis. Chronic bloody diarrhoea requires stool culture and C. difficile testing before escalating immunosuppression. Colonoscopy with biopsies confirms extent and chronicity; flexible sigmoidoscopy is often preferred initially in severe colitis. Faecal calprotectin supports inflammatory rather than functional disease but does not identify the cause.
5-ASA is the usual foundation for mild-to-moderate disease, with topical treatment important in proctitis and left-sided disease. Corticosteroids induce remission and should be tapered; they are not maintenance therapy. Steroid dependence, moderate-to-severe disease or high-risk endoscopic features should trigger specialist advanced-therapy planning. Thiopurines are slow-onset maintenance or combination agents in selected patients, not emergency rescue.
ASUC is an inpatient emergency: intravenous steroids, infection testing, thromboprophylaxis, objective reassessment and early colorectal-surgery involvement are key. Toxic megacolon, perforation, uncontrolled haemorrhage or failure of rescue therapy may require colectomy. Longstanding extensive colitis increases colorectal-cancer surveillance needs. Vaccines, tuberculosis and hepatitis B screening, bone health and pregnancy planning are part of safe care, not optional extras.
Frequently Asked Questions
Can a stool infection test alone distinguish ulcerative colitis from infection?
No. Stool culture or molecular testing and C. difficile assessment are essential, but results must be interpreted with exposure history, endoscopy, biopsy and the clinical course. Some pathogens are not covered by every panel, prior antibiotics can alter results, and inflammatory bowel disease can coexist with infection. Persistent or severe symptoms need specialist reassessment rather than an automatic diagnosis.
Are steroids a long-term treatment for ulcerative colitis?
No. Corticosteroids can induce improvement during a flare, but repeated or prolonged exposure causes infection, bone, metabolic, adrenal and other harms and signals a need to optimise steroid-sparing therapy. A supervised taper, objective response assessment and maintenance plan are required. Worsening during tapering should prompt review for infection, undertreated disease or steroid dependence.
Is biologic treatment always unsafe during pregnancy?
No. The decision depends on the medicine, disease activity, prior response, timing and maternal-fetal advice. Uncontrolled UC can itself harm pregnancy through inflammation, dehydration, malnutrition and steroid exposure. Patients should not stop effective maintenance therapy abruptly. Gastroenterology and obstetric teams should review conception, vaccination, infection screening, dosing and infant vaccine planning individually.
When does ulcerative colitis require surgery?
Urgent surgery may be needed for perforation, toxic megacolon, uncontrolled bleeding, severe systemic deterioration or failure of time-limited medical rescue in acute severe colitis. Elective colectomy can also be discussed for cancer or dysplasia, medically refractory disease, steroid dependence or unacceptable quality-of-life burden. Colorectal surgeons should be involved early so choices and reconstruction planning are not made during a crisis.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- a growing library of visual revision sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Clinical GuidesAll Clinical Guides
Browse all clinical management guides for Indian medical practice.
Test your knowledge
Attempt structured MCQs on this topic to consolidate your understanding and connect the guide to exam-focused practice.
Try MCQs on this topic